China Beckons to Clinical Trial Sponsors  

Oleh:

Hepeng Jia

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 7 (Jul. 2005), page 768.
Topik: CLINICAL PATHOLOGY; beckons; clinical trial sponsors

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.3 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

The clinical trials market is opening up in china. The most recent evidence has been provided by the danish centre for clinical and basic research (CCBR), which announced its intention to establish clinical research facilities in beijing, independent of the state authorities. Low cost and ease of access to patients are the main incentives for clinical trial outsourcing. But several hurdles face biotech companies looking to locate their trials in china, including poor data standardization, delays in gaining trial authorization from regulators and questionable ethical standards.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali